摘要 |
The present invention is to .mu.-conopeptides, derivatives or pharmaceutical ly acceptable salts thereof. The present invention is further directed to the u se of this peptide, derivatives thereof and pharmaceutically acceptable salts thereof for the treatment of disorders associated with voltage-gated sodium channels. Thus, the .mu.-conopeptides or derivatives are useful as neuromuscular blocking agents, local anesthetic agents, analgesic agents and neuroprotective agents. The .mu.-conopeptides are also useful for treating neuromuscular disorders. The invention is further directed to nucleic acid sequences encoding the .mu.-conopeptides and encoding propeptides, as well a s the propeptides.
|
申请人 |
UNIVERSITY OF UTAH RESEARCH FOUNDATION;COGNETIX, INC. |
发明人 |
JACOBSEN, RICHARD B.;CARTIER, G. EDWARD;JONES, ROBERT M.;SHON, KI-JOON;OLIVERA, BALDOMERO M.;MCINTOSH, J. MICHAEL;GARRETT, JAMES E.;CRUZ, LOURDES J.;WATKINS, MAREN;SHEN, GREGORY S.;WAGSTAFF, JOHN D. |